Ubs Group Ag Danaher Corp Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $33.1 Million - $38.8 Million	138,300 Added 139.42%	237,500 $66 Million
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $9.87 Million - $11.2 Million	-41,896 Reduced 29.69%	99,200 $24.8 Million
Q1 2024 May 13, 2024	SELL	$224.58 - $256.19 $2.78 Million - $3.18 Million	-12,396 Reduced 8.08%	141,096 $35.2 Million
Q4 2023 Feb 09, 2024	SELL	$185.1 - $233.13 $5.15 Million - $6.48 Million	-27,808 Reduced 15.34%	153,492 $35.5 Million
Q3 2023 Nov 09, 2023	BUY	$233.08 - $265.59 $19.2 Million - $21.8 Million	82,200 Added 82.95%	181,300 $45 Million
Q2 2023 Aug 11, 2023	BUY	$224.99 - $256.14 $15.4 Million - $17.6 Million	68,600 Added 224.92%	99,100 $23.8 Million
Q1 2023 May 12, 2023	SELL	$239.75 - $277.0 $32.2 Million - $37.1 Million	-134,100 Reduced 81.47%	30,500 $7.69 Million
Q4 2022 Feb 08, 2023	BUY	$241.42 - $282.29 $1.5 Million - $1.75 Million	6,200 Added 3.91%	164,600 $43.7 Million
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $2.57 Million - $15.7 Million	10,400 Added 7.03%	158,400 $40.9 Million
Q2 2022 Aug 10, 2022	BUY	$237.11 - $299.66 $71,133 - $89,898	300 Added 0.2%	148,000 $37.5 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $154,362 - $189,456	600 Added 0.41%	147,700 $43.3 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $24.5 Million - $27.6 Million	83,770 Added 132.28%	147,100 $48.4 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $10.6 Million - $12.9 Million	38,800 Added 158.17%	63,330 $19.3 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $225,080 - $271,690	1,000 Added 4.25%	24,530 $6.58 Million
Q1 2021 May 12, 2021	SELL	$212.38 - $245.9 $1.31 Million - $1.52 Million	-6,170 Reduced 20.77%	23,530 $5.3 Million
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $1.68 Million - $1.94 Million	7,900 Added 36.24%	29,700 $6.6 Million
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $3.56 Million - $4.33 Million	20,100 Added 1182.35%	21,800 $4.7 Million
Q2 2020 Jul 31, 2020	SELL	$128.7 - $176.83 $10.5 Million - $14.4 Million	-81,600 Reduced 97.96%	1,700 $301,000
Q1 2020 May 01, 2020	BUY	$121.39 - $169.05 $6.97 Million - $9.7 Million	57,400 Added 221.62%	83,300 $11.5 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $3.39 Million - $3.66 Million	25,000 Added 2777.78%	25,900 $3.74 Million
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $62,440 - $71,865	-500 Reduced 35.71%	900 $129,000
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $780,960 - $1.06 Million	-8,000 Reduced 85.11%	1,400 $185,000
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $654,465 - $755,826	6,900 Added 276.0%	9,400 $969,000
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $215,886 - $239,580	2,200 Added 733.33%	2,500 $272,000
Q2 2018 Aug 14, 2018	SELL	$96.1 - $103.24 $922,560 - $991,104	-9,600 Reduced 96.97%	300 $30,000
Q1 2018 May 15, 2018	BUY	$92.16 - $103.8 $377,856 - $425,580	4,100 Added 70.69%	9,900 $969,000
Q2 2017 Aug 14, 2017	SELL	N/A	-200 Reduced 3.33%	5,800 $489,000
Q1 2017 Nov 14, 2017	BUY	N/A	6,000	6,000 $513,000

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

Vanguard Group Inc Valley Forge, PA

59.4M
Shares

$13.6 Billion
0.3% of portfolio
Black Rock Inc. New York, NY

50.5M
Shares

$11.6 Billion
0.29% of portfolio
State Street Corp Boston, MA

27.5M
Shares

$6.31 Billion
0.32% of portfolio
Wellington Management Group LLP Boston, MA

23.3M
Shares

$5.35 Billion
1.16% of portfolio
Price T Rowe Associates Inc Baltimore, MD

20.5M
Shares

$4.7 Billion
0.66% of portfolio

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $167B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account